Ads
related to: generic drug companies
Search results
GlaxoSmithKline Pharma India posts higher Q4 adjusted profit on strong sales
Reuters· 5 days ago, opens new tab reported a 49% rise in fourth-quarter adjusted profit on Friday, as strong demand for its generic medicines offset the impact of the government's ongoing price ...
AstraZeneca Aims for $80 Billion in Total Revenue by 2030
US News & World Report· 1 day agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier expected to launch at least 15 new medicines between 2023 and 2030. CEO Pascal Soriot has turned ...
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
Digital Journal· 2 days ago("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it ...
Walgreens launches a cheaper, generic version of over-the-counter Narcan
Scripps News via AOL· 7 days agoWalgreens announced it will begin selling its own generic version of the lifesaving medication...
Hims Debuts $199 Weight-Loss Shots at 85% Discount to Wegovy
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- In just a few years, Hims & Hers Health Inc. reached almost $1 billion in sales by...
Trendy SF wellness company unveils cheap copycat of Ozempic
San Francisco Chronicle· 2 days agoHims & Hers Health has grown into a telehealth giant by making it easier to order generic versions...
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 2 days agoMerck & Co., Inc. Price and Consensus Merck & Co., Inc. price-consensus-chart | Merck & Co., Inc....
Walgreens is launching a generic version of over-the-counter Narcan
NBC News via Yahoo News· 7 days agoWalgreens said Wednesday that it will sell its own generic version of over-the-counter Narcan, the...
India's Biocon posts Q4 profit fall as higher raw material costs bite
Reuters via Yahoo Finance· 6 days agoIndian biopharmaceutical company Biocon reported a decline in its fourth-quarter profit on Thursday, as soaring raw material costs overshadowed growth in its biosimilar business ...
HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections
InvestorPlace· 2 days agoHims & Hers has partnered with an undisclosed manufacturer of generic and 503B compounded injectable...